These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25935484)

  • 41. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
    Denorme M; Yon L; Roux C; Gonzalez BJ; Baudin E; Anouar Y; Dubessy C
    Cancer Lett; 2014 Oct; 352(2):236-44. PubMed ID: 25016061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-dependent response of tumor vasculature to radiation therapy in combination with Sunitinib depicted by three-dimensional high-frequency power Doppler ultrasound.
    El Kaffas A; Giles A; Czarnota GJ
    Angiogenesis; 2013 Apr; 16(2):443-54. PubMed ID: 23314761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular imaging of changes in the prevalence of vascular endothelial growth factor receptor in sunitinib-treated murine mammary tumors.
    Levashova Z; Backer M; Hamby CV; Pizzonia J; Backer JM; Blankenberg FG
    J Nucl Med; 2010 Jun; 51(6):959-66. PubMed ID: 20484434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
    Qiu H; Wang GM
    Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of tumor response to radiation and vascular targeting therapy in mice using quantitative ultrasound spectroscopy.
    El Kaffas A; Sadeghi-Naini A; Falou O; Tran WT; Zhou S; Hashim A; Fernandes J; Giles A; Czarnota GJ
    Med Phys; 2015 Aug; 42(8):4965-73. PubMed ID: 26233222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Irradiation on Tumor Microenvironment and Bone Marrow Cell Migration in a Preclinical Tumor Model.
    Kane JL; Krueger SA; Hanna A; Raffel TR; Wilson GD; Madlambayan GJ; Marples B
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):170-8. PubMed ID: 27511854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mannatide enhances the efficacy of fractionated and unfractionated radiotherapy in mice bearing Lewis lung cancer].
    Fan RT; Hu Y; Liu JQ; Zhang JJ; Song R; Gu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2072-5. PubMed ID: 22200715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton irradiation augments the suppression of tumor progression observed with advanced age.
    Beheshti A; Peluso M; Lamont C; Hahnfeldt P; Hlatky L
    Radiat Res; 2014 Mar; 181(3):272-83. PubMed ID: 24568128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiangiogenic therapy using sunitinib combined with rapamycin retards tumor growth but promotes metastasis.
    Yin T; He S; Ye T; Shen G; Wan Y; Wang Y
    Transl Oncol; 2014 Apr; 7(2):221-9. PubMed ID: 24742865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Challenges and opportunities of using stereotactic body radiotherapy with anti-angiogenesis agents in tumor therapy.
    Sun X; Deng L; Lu Y
    Chin J Cancer Res; 2018 Feb; 30(1):147-156. PubMed ID: 29545728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fuzi Enhances Anti-Tumor Efficacy of Radiotherapy on Lung Cancer.
    Zhang Q; Chen X; Luo Y; Ren H; Qiao T
    J Cancer; 2017; 8(19):3945-3951. PubMed ID: 29187869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of combined sunitinib and extracranial stereotactic radiotherapy on bone marrow hematopoiesis.
    Kao J; Timmins J; Ozao-Choy J; Packer S
    Oncol Lett; 2016 Sep; 12(3):2139-2144. PubMed ID: 27602153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further rationale for optimal combined modality treatments.
    Griffin RJ; Dings RPM; Makhoul I
    Oncotarget; 2017 Apr; 8(16):25831-25832. PubMed ID: 28415727
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study.
    Harari S; Caminati A; Albera C; Vancheri C; Poletti V; Pesci A; Luppi F; Saltini C; Agostini C; Bargagli E; Sebastiani A; Sanduzzi A; Giunta V; Della Porta R; Bandelli GP; Puglisi S; Tomassetti S; Biffi A; Cerri S; Mari A; Cinetto F; Tirelli F; Farinelli G; Bocchino M; Specchia C; Confalonieri M
    Respir Med; 2015 Jul; 109(7):904-13. PubMed ID: 25962649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of novel agents for idiopathic pulmonary fibrosis: progress in target selection and clinical trial design.
    O'Riordan TG; Smith V; Raghu G
    Chest; 2015 Oct; 148(4):1083-1092. PubMed ID: 26020856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy.
    Spagnolo P; Maher TM; Richeldi L
    Pharmacol Ther; 2015 Aug; 152():18-27. PubMed ID: 25946646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Idiopathic pulmonary fibrosis: the turning point is now!
    Funke M; Geiser T
    Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model.
    Blunt MD; Carter MJ; Larrayoz M; Smith LD; Aguilar-Hernandez M; Cox KL; Tipton T; Reynolds M; Murphy S; Lemm E; Dias S; Duncombe A; Strefford JC; Johnson PW; Forconi F; Stevenson FK; Packham G; Cragg MS; Steele AJ
    Blood; 2015 Jun; 125(26):4032-41. PubMed ID: 25957390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.
    Staab-Weijnitz CA; Fernandez IE; Knüppel L; Maul J; Heinzelmann K; Juan-Guardela BM; Hennen E; Preissler G; Winter H; Neurohr C; Hatz R; Lindner M; Behr J; Kaminski N; Eickelberg O
    Am J Respir Crit Care Med; 2015 Aug; 192(4):455-67. PubMed ID: 26039104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts.
    Yamagami K; Oka T; Wang Q; Ishizu T; Lee JK; Miwa K; Akazawa H; Naito AT; Sakata Y; Komuro I
    Am J Physiol Heart Circ Physiol; 2015 Aug; 309(3):H512-22. PubMed ID: 26055790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.